COMBINATION ANTRIRETROVIRAL REGIMENS AND TREATMENT-SWITCHING STRATEGIES IN CHILD

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 这项研究的目的是评估两种不同的抗艾滋病毒药物治疗组合，并确定从一种治疗组合转换到另一种治疗组合的两种计划中哪一种更好。 该研究将评估在四年的治疗中，两种转换计划中的任何一种是否有获益差异。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this research study is to evaluate two different treatment combinations of anti-HIV drugs, and to determine which of two plans for switching from one to the other treatment combination is better. The study will evaluate if there is a difference in benefit for either of the two switching plans in a four-year treatment.